-
Baase WA, Liu L, Tronrud DE, Matthews BW, 2010: Lessons from the lysozyme of phage T4[J]. Protein Science, 19, 631-641. doi: 10.1002/pro.344
-
Borysowski J, Weber-Dabrowska B, Gorski A, 2006: Bacteriophage endolysins as a novel class of antibacterial agents[J]. Exp Biol Med, 231, 366-377. doi: 10.1177/153537020623100402
-
Briers Y, Walmagh M, Lavigne R, 2011: Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa[J]. J Appl Microbiol, 110, 778-785. doi: 10.1111/jam.2011.110.issue-3
-
Burrowes B, Harper DR, Anderson J, McConville M, Enright MC, 2011: Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens[J]. Expert Rev Anti Infect Ther, 9, 775-785. doi: 10.1586/eri.11.90
-
Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, Huang DB, Dupont MW, Adachi JA, De La Cabada FJ, Taylor DN, Jaini S, Martinez SF, 2007: Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone[J]. Clin Gastroenterol Hepatol, 5, 451-456. doi: 10.1016/j.cgh.2007.02.004
-
Endersen L, Guinane CM, Johnston C, Neve H, Coffey A, Ross RP, McAuliffe O, O'Mahony J, 2015: Genome analysis of Cronobacter phage vB_CsaP_Ss1 reveals an endolysin with potential for biocontrol of Gram-negative bacterial pathogens[J]. J Gen Virol, 96, 463-477. doi: 10.1099/vir.0.068494-0
-
Eriksson AE, Baase WA, Wozniak JA, Matthews BW, 1992: A cavity-containing mutant of T4 lysozyme is stabilized by buried benzene[J]. Nature, 355, 371-373. doi: 10.1038/355371a0
-
Fischetti VA, 2008: Bacteriophage lysins as effective antibacterials[J]. Curr Opin Microbiol, 11, 393-400. doi: 10.1016/j.mib.2008.09.012
-
Fischetti VA, 2010: Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens[J]. Int J Med Microbiol, 300, 357-362. doi: 10.1016/j.ijmm.2010.04.002
-
Legotsky SA, Vlasova KY, Priyma AD, Shneider MM, Pugachev VG, Totmenina OD, Kabanov AV, Miroshnikov KA, Klyachko NL, 2014: Peptidoglycan degrading activity of the broad-range Salmonella bacteriophage S-394 recombinant endolysin[J]. Biochimie, 107, 293-299. doi: 10.1016/j.biochi.2014.09.017
-
Li H, Ma ML, Xie HJ, Kong J, 2012: Biosafety evaluation of bacteriophages for treatment of diarrhea due to intestinal pathogen Escherichia coli 3-2 infection of chickens[J]. World J Microbiol Biotechnol, 28, 1-6. doi: 10.1007/s11274-011-0784-5
-
Lim J A, Shin H, Heu S, Ryu S, 2014: Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria[J]. J Microbiol Biotechnol, 24, 803-811. doi: 10.4014/jmb.1403.03035
-
Liu L, Baase WA, Michael MM, Matthews BW, 2009: Use of stabilizing mutations to engineer a charged group within a ligandbinding hydrophobic cavity in T4 lysozyme[J]. Biochemistry, 48, 8842-8851. doi: 10.1021/bi900685j
-
Liu L, Quillin ML, Matthews BW, 2008: Use of experimental crystallographic phases to examine the hydration of polar and nonpolar cavities in T4 lysozyme[J]. Proc Natl Acad Sci USA, 105, 14406-14411. doi: 10.1073/pnas.0806307105
-
López CJ, Yang Z, Altenbach C, Hubbell WL, 2013: Conformational selection and adaptation to ligand binding in T4 lysozyme cavity mutants[J]. Proc Natl Acad Sci U S A, 110, E4306-E4315. doi: 10.1073/pnas.1318754110
-
Lukacik P, Barnard TJ, Hinnebusch BJ, Buchanan SK, 2013: Specific targeting and killing of Gram-negative pathogens with an engineered phage lytic enzyme[J]. Virulence, 4, 90-91. doi: 10.4161/viru.22683
-
Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM, 2012: Endolysins as antimicrobials[J]. Virus Res, 83, 299-365. doi: 10.1016/B978-0-12-394438-2.00007-4
-
Oliveira H, Melo LD, Santos SB, Nóbrega FL, Ferreira EC, Cerca N, Azeredo J, Kluskens LD, 2013: Molecular aspects and comparative genomics of bacteriophage endolysins[J]. J Virol, 87, 4558-4570. doi: 10.1128/JVI.03277-12
-
Oliveira H, Thiagarajan V, Walmagh M, Sillankorva S, Lavigne R, Neves-Petersen MT, Kluskens LD, Azeredo J, 2014: A Thermostable Salmonella Phage Endolysin, Lys68, with Broad Bactericidal Properties against Gram-Negative Pathogens in Presence of Weak Acids[J]. PLoS One, 9, e108376-. doi: 10.1371/journal.pone.0108376
-
Olsen RH, Frantzen C, Christensen H, Bisgaard M, 2012: An investigation on first-week mortality in layers[J]. Avian Dis, 56, 51-57. doi: 10.1637/9777-051011-Reg.1
-
Trudil D, 2015: Phage lytic enzymes: a history[J]. Virol Sin, 30, 26-32. doi: 10.1007/s12250-014-3549-0
-
Xu J, Baase WA, Baldwin E, Matthews BW, 1998: The response of T4 lysozyme to large-to-small substitutions within the core and its relation to the hydrophobic effect[J]. Protein Science, 7, 158-177. doi: 10.1002/pro.5560070117
-
Xu Y, Liu Y, Liu Y, Pei J, Yao S, Cheng C, 2015: Bacteriophage therapy against Enterobacteriaceae[J]. Virol Sin, 30, 11-8. doi: 10.1007/s12250-014-3543-6
-
Zhang C, Li W, Liu W, Zou L, Yan C, Lu K, Ren H, 2013: T4-like phage Bp7, a potential antimicrobial agent for controlling drugresistant Escherichia coli in chickens[J]. Appl Environ Microbiol, 79, 5559-5565. doi: 10.1128/AEM.01505-13
-
Zhang T, Wang CG, Lv JC, Wang RS, Zhong XH, 2012: Survey on tetracycline resistance and antibiotic-resistant genotype of avian Escherichia coli in North China[J]. Poult Sci, 91, 2774-2777. doi: 10.3382/ps.2012-02453